Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
Daxor (Nasdaq: DXR), the global leader in blood volume measurement technology, announces its participation in the 2024 Maxim Healthcare Virtual Summit. CEO and President Michael Feldschuh will engage in a fireside chat with Maxim's Director of Research and Senior Healthcare Analyst Anthony Vendetti on Tuesday, October 15, 2024, at 10:00 AM ET.
The summit runs from October 15 – 17, 2024. Investors can access the fireside chat via webcast at https://m-vest.com/events/healthcare-10152024. Mr. Feldschuh will also be available for one-on-one meetings with registered summit investors. Interested parties can contact Bret Shapiro at CORE IR by calling 1-516-222-2560 or emailing brets@coreir.com to arrange meetings.
Daxor (Nasdaq: DXR), il leader globale nella tecnologia di misurazione del volume sanguigno, annuncia la sua partecipazione al 2024 Maxim Healthcare Virtual Summit. L'Amministratore Delegato e Presidente Michael Feldschuh parteciperà a una chiacchierata informale con il Direttore Ricerca e Senior Healthcare Analyst di Maxim, Anthony Vendetti, martedì 15 ottobre 2024, alle 10:00 AM ET.
Il summit si svolge dal 15 al 17 ottobre 2024. Gli investitori possono accedere alla chiacchierata informale tramite webcast all'indirizzo https://m-vest.com/events/healthcare-10152024. Il Sig. Feldschuh sarà inoltre disponibile per incontri individuali con gli investitori registrati al summit. Le parti interessate possono contattare Bret Shapiro di CORE IR chiamando il 1-516-222-2560 oppure inviando un'email a brets@coreir.com per organizzare gli incontri.
Daxor (Nasdaq: DXR), el líder mundial en tecnología de medición del volumen sanguíneo, anuncia su participación en el 2024 Maxim Healthcare Virtual Summit. El CEO y Presidente Michael Feldschuh participará en una charla informal con el Director de Investigación y Analista Senior de Salud de Maxim, Anthony Vendetti, el martes 15 de octubre de 2024, a las 10:00 AM ET.
El summit se llevará a cabo del 15 al 17 de octubre de 2024. Los inversores pueden acceder a la charla informal a través de un webcast en https://m-vest.com/events/healthcare-10152024. El Sr. Feldschuh también estará disponible para reuniones individuales con los inversores registrados del summit. Las partes interesadas pueden contactar a Bret Shapiro de CORE IR llamando al 1-516-222-2560 o enviando un correo electrónico a brets@coreir.com para organizar las reuniones.
Daxor (Nasdaq: DXR), 전혈 용적 측정 기술의 글로벌 리더, 2024 Maxim Healthcare Virtual Summit에 참여한다고 발표했습니다. CEO이자 회장인 Michael Feldschuh는 Maxim의 연구 이사이자 수석 건강 분석가인 Anthony Vendetti와 함께 2024년 10월 15일 화요일 오전 10시(ET)에 대담을 진행할 예정입니다.
이번 서밋은 2024년 10월 15일부터 17일까지 진행됩니다. 투자자는 https://m-vest.com/events/healthcare-10152024를 통해 웹캐스트로 대담을 시청할 수 있습니다. Feldschuh씨는 또한 등록된 서밋 투자자들과의 일대일 미팅을 위해 대기하고 있습니다. 관심이 있는 분들은 CORE IR의 Bret Shapiro에게 전화 1-516-222-2560 또는 이메일 brets@coreir.com으로 연락하여 미팅 일정을 잡을 수 있습니다.
Daxor (Nasdaq: DXR), le leader mondial de la technologie de mesure du volume sanguin, annonce sa participation au 2024 Maxim Healthcare Virtual Summit. Le PDG et Président Michael Feldschuh participera à une discussion informelle avec le Directeur de Recherche et Analyste Senior en Santé de Maxim, Anthony Vendetti, mardi 15 octobre 2024 à 10h00 ET.
Le sommet se déroulera du 15 au 17 octobre 2024. Les investisseurs peuvent accéder à la discussion informelle via un webcast à l'adresse https://m-vest.com/events/healthcare-10152024. M. Feldschuh sera également disponible pour des réunions individuelles avec les investisseurs enregistrés au sommet. Les parties intéressées peuvent contacter Bret Shapiro de CORE IR en appelant le 1-516-222-2560 ou en envoyant un e-mail à brets@coreir.com pour organiser des réunions.
Daxor (Nasdaq: DXR), der globale Marktführer in der Technologie zur Messung des Blutvolumens, gibt seine Teilnahme am 2024 Maxim Healthcare Virtual Summit bekannt. CEO und Präsident Michael Feldschuh wird am Dienstag, den 15. Oktober 2024, um 10:00 Uhr ET ein informelles Gespräch mit Maxims Forschungsdirektor und leitendem Gesundheitsanalysten Anthony Vendetti führen.
Der Summit findet vom 15. bis 17. Oktober 2024 statt. Investoren können das informelle Gespräch über einen Webcast unter https://m-vest.com/events/healthcare-10152024 verfolgen. Herr Feldschuh wird auch für Einzelgespräche mit registrierten Summit-Investoren zur Verfügung stehen. Interessierte Parteien können Bret Shapiro von CORE IR unter der Nummer 1-516-222-2560 anrufen oder eine E-Mail an brets@coreir.com senden, um Meetings zu vereinbaren.
- None.
- None.
Oak Ridge, TN, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit with Maxim Director of Research and Senior Healthcare Analyst Anthony Vendetti. The summit is being held from October 15 – 17, 2024.
| Event: | Fireside Chat at 2024 Maxim Healthcare Virtual Summit |
| Date: | Tuesday, October 15, 2024 |
| Time: | 10:00 AM ET |
| Webcast: | https://m-vest.com/events/healthcare-10152024 |
Mr. Feldschuh will be available for one-on-one meetings with registered investors of the summit.
Interested investors may also contact Bret Shapiro at CORE IR either by calling 1-516-222-2560 or emailing brets@coreir.com.
About Daxor Corporation
Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100™ (Blood Volume Analyzer), the only diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at leading hospital centers across the U.S., enhancing hospital performance metrics in a broad range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. Daxor has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the U.S. Department of Defense. Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for all. For more information, please visit our website at Daxor.com. Sign up to receive news on Daxor’s innovative technology HERE.
Forward-Looking Statements
Certain statements in this release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation statements regarding the impact of hiring sales staff and expansion of our distribution channels. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risk associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and additional other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether because of new information, future events or otherwise.
Investor Relations Contact:
Bret Shapiro
Sr. Managing Partner, CORE IR
1-516-222-2560
brets@coreir.com
FAQ
When is Daxor (DXR) participating in the 2024 Maxim Healthcare Virtual Summit?
Who will represent Daxor (DXR) at the 2024 Maxim Healthcare Virtual Summit?
How can investors access Daxor 's (DXR) fireside chat at the 2024 Maxim Healthcare Virtual Summit?
What is the date range for the 2024 Maxim Healthcare Virtual Summit featuring Daxor (DXR)?
How can investors arrange one-on-one meetings with Daxor (DXR) during the 2024 Maxim Healthcare Virtual Summit?
